IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) — MUSE Microscopy, (the “Company”, “we”, “our”) a leader in slide-free, tissue-to-digital(TM) pathology solutions, is excited to announce its participation in the upcoming American Society of Clinical Oncology (ASCO) 2025, taking place from May 30 – June 03 in Chicago, IL. Following our successful introduction of SmartPath MUSE […]
Leading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCO GlobeNewswire May 29, 2025 IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) — MUSE Microscopy, (the “Company”, “we”, “our”) a leader in slide-free, tissue-to-digital(TM) pathology solutions, is excited to announce its participation in the upcoming American Society of Clinical Oncology (ASCO) 2025, taking
Flor de Caña, the renowned premium rum brand, and Danil Nevsky, recognized as the #2 World's Most Influential Bartender, recently joined forces to launch a high-profile sustainable guest bartending tour across the country to celebrate cocktail innovation and environmental responsibility. https://mma.prnewswire.com/media/2699505/Flor_de_Cana_Rum_x_Danil_Nevsky.jpg This exciting initiative showcased the power of sustainability as a driving force in the
Itaú Unibanco HoldingS.A. informs its stockholders that its Board of Directors has approved, at the meeting held on this date, the payment of interest on capital to stockholders (“IOC”) in the amount of R$0.3341 per share, with income tax withholding at a rate of 15%, resulting in net interest of R$0.283985 per share, except for
Centrus Energy Corp. (NYSE American: LEU) today announced that management will participate in the following upcoming conferences. https://mma.prnewswire.com/media/840946/Centrus_Energy__Logo.jpg — On Tuesday, June 3, management is scheduled to host one-on-one investor meetings at the Stifel 2025 Boston Cross Sector 1×1 Conference in Boston, MA. — On Wednesday, June 4, management is scheduled to host one-on-one investor
The B-cell inhibitors market is experiencing robust growth, driven by the rising prevalence of the addressable patient population, which includes indications like IgAN, Multiple Sclerosis, Immune Thrombocytopenia, SLE, IgG4-RD, wAIHA, NMOSD, Lupus Nephritis, ANCA Vasculitis, CSU, and others. Increasing R&D investment and regulatory approvals are further accelerating market expansion. DelveInsight's B-cell Inhibitor Market Size, Target
NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / WHY: New York, N.Y., May 29, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ:ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with
NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / WHY: New York, N.Y., May 29, 2025. Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ:GOCO) resulting from allegations that GoHealth may have issued materially misleading business information
NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / WHY: New York, N.Y., May 29, 2025. Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE:SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information
NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / WHY: New York, N.Y., May 29, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ:VTRS) between August 8, 2024 and February 26, 2025, both dates inclusive (the "Class Period"), of the important June 3,